Randomized, Double-Masked, Sham-Controlled Trial of Ranibizumab for Neovascular Age-related Macular Degeneration: PIER Study Year 1 - Concepedia

Concepedia

Publication | Closed Access

Randomized, Double-Masked, Sham-Controlled Trial of Ranibizumab for Neovascular Age-related Macular Degeneration: PIER Study Year 1

859

Citations

12

References

2008

Year

Carl D. Regillo, David M. Brown, Prema Abraham, Huibin Yue, Tsontcho Ianchulev, Susan Schneider, Naveed Shams

American Journal of Ophthalmology

Ocular DiseaseOphthalmologyExperimental OphthalmologyAge-related DiseasesSham-controlled TrialGlaucomaMedicine

References

	Year	Citations

Page 1